REVB
Revelation Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.18M
P/E Ratio
—
EPS
$-1.32
Beta
-0.14
52W High
$30.00
52W Low
$0.88
50-Day MA
$1.14
200-Day MA
$3.90
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.89
PEG Ratio
—
About Revelation Biosciences Inc
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $90.91M |
| EBITDA | $-10.04M |
| Operating Margin | 0.00% |
| Return on Equity | -124.40% |
| Return on Assets | -66.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.32 |
| Price-to-Book | 0.32 |
| Price-to-Sales (TTM) | 2.88 |
| EV/Revenue | - |
| EV/EBITDA | -1.02 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.91M |
| Float | $3.44M |
| % Insiders | 4.79% |
| % Institutions | 12.79% |
Historical Volatility
HV 10-Day
60.37%
HV 20-Day
54.02%
HV 30-Day
50.80%
HV 60-Day
57.06%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($19.25 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026